FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mueller Henning

2. Date of Event Requiring Statement (MM/DD/YYYY)
3/5/2018 

3. Issuer Name and Ticker or Trading Symbol

DENTSPLY SIRONA Inc. [XRAY]

(Last)        (First)        (Middle)

221 W PHILADELPHIA ST, STE 60W

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Group VP, Asia Pacific RCO /

(Street)

YORK, PA 17401       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   6734.783   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)     (1) 11/26/2023   Common Stock   1361   $37.26   D    
Stock Option (Right to Buy)     (2) 11/25/2024   Common Stock   2086   $47.41   D    
Stock Option (Right to Buy)     (3) 2/22/2027   Common Stock   6200   $62.34   D    

Explanation of Responses:
(1)  This option is fully vested and exercisable.
(2)  25% vested 11/25/2015, 25% vested 11/25/2016, 20% vested 11/25/2017, 20% vests 11/25/2018 & the final 10% shall vest 11/25/2019.
(3)  Stock Options vest in annual one-third (1/3) increments over a three-year period ending February 22, 2020.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mueller Henning
221 W PHILADELPHIA ST, STE 60W
YORK, PA 17401

Group VP, Asia Pacific RCO

Signatures
Dane Baumgardner, Attorney-In-Fact for Henning Mueller 3/15/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more DENTSPLY SIRONA Charts.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more DENTSPLY SIRONA Charts.